Pages that link to "Q56992767"
Jump to navigation
Jump to search
The following pages link to Identification of Serum-Derived Sphingosine-1-Phosphate as a Small Molecule Regulator of YAP (Q56992767):
Displaying 50 items.
- Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP (Q24298571) (← links)
- Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks (Q26738344) (← links)
- Regulation of TAZ in cancer (Q26740462) (← links)
- G Protein-Coupled Receptors in Cancer (Q26741203) (← links)
- Mechanisms of Hippo pathway regulation (Q26771285) (← links)
- A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas (Q26782842) (← links)
- The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment (Q27025661) (← links)
- The sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity (Q27316144) (← links)
- Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy (Q28078129) (← links)
- YAP and TAZ: a nexus for Hippo signaling and beyond (Q28085636) (← links)
- Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer (Q28086905) (← links)
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer (Q28269498) (← links)
- Histone acetylation-mediated regulation of the Hippo pathway (Q28487649) (← links)
- Actin cytoskeleton regulates Hippo signaling (Q28533309) (← links)
- Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway (Q30278951) (← links)
- The Hippo signaling pathway in stem cell biology and cancer (Q30410176) (← links)
- What do mechanotransduction, Hippo, Wnt, and TGFβ have in common? YAP and TAZ as key orchestrating molecules in ocular health and disease (Q30429628) (← links)
- Angiomotins link F-actin architecture to Hippo pathway signaling (Q33604410) (← links)
- Framework to function: mechanosensitive regulators of gene transcription (Q33634664) (← links)
- The Hippo pathway in disease and therapy: cancer and beyond (Q33937666) (← links)
- Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis (Q34376255) (← links)
- Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein (Q34469155) (← links)
- The hippo pathway in heart development, regeneration, and diseases (Q34470968) (← links)
- The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity. (Q34685404) (← links)
- Prenatal exposure to dietary fat induces changes in the transcriptional factors, TEF and YAP, which may stimulate differentiation of peptide neurons in rat hypothalamus (Q35023315) (← links)
- Intraovarian control of early folliculogenesis (Q35024088) (← links)
- Phenotypic regulation of the sphingosine 1-phosphate receptor miles apart by G protein-coupled receptor kinase 2. (Q35027128) (← links)
- Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway (Q35236207) (← links)
- Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy (Q35484837) (← links)
- Inhibition of RHO-ROCK signaling enhances ICM and suppresses TE characteristics through activation of Hippo signaling in the mouse blastocyst (Q35500567) (← links)
- Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP. (Q35563057) (← links)
- Estrogen regulates Hippo signaling via GPER in breast cancer (Q35720044) (← links)
- Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness (Q35925760) (← links)
- A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis. (Q36027005) (← links)
- RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3. (Q36079567) (← links)
- Pancreas lineage allocation and specification are regulated by sphingosine-1-phosphate signalling (Q36293831) (← links)
- Yap is required for ependymal integrity and is suppressed in LPA-induced hydrocephalus (Q36511419) (← links)
- Role of substratum stiffness in modulating genes associated with extracellular matrix and mechanotransducers YAP and TAZ (Q36676552) (← links)
- The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells (Q36847992) (← links)
- Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation (Q36948973) (← links)
- Substratum stiffness and latrunculin B modulate the gene expression of the mechanotransducers YAP and TAZ in human trabecular meshwork cells. (Q37079926) (← links)
- Verteporfin, a suppressor of YAP-TEAD complex, presents promising antitumor properties on ovarian cancer (Q37229782) (← links)
- Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases (Q37255948) (← links)
- Integration of mechanical and chemical signals by YAP and TAZ transcription coactivators (Q37361741) (← links)
- Disease implication of hyper-Hippo signalling (Q37385782) (← links)
- CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation (Q37388129) (← links)
- Beyond the niche: tissue-level coordination of stem cell dynamics (Q37500412) (← links)
- Regulation of the Hippo pathway and implications for anticancer drug development (Q37593084) (← links)
- G-protein-coupled receptors mediate ω-3 PUFAs-inhibited colorectal cancer by activating the Hippo pathway (Q37629024) (← links)
- The role of extracellular biophysical cues in modulating the Hippo-YAP pathway. (Q37689217) (← links)